Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.48%
#4 aPriori aPriori +113.53%
#5 Bedrock Bedrock +74.54%
#6 Cysic Cysic +46.36%
#7 Prom Prom +40.86%
#8 Playnance Playnance +35.16%
#9 COTI COTI +30.93%
#10 Nillion Nillion +22.86%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classement en actions #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Prix de l'action
$0.00023723
Dernière synchronisation: 2024-08-26
Capitalisation boursière
$1.41K
Changement (1 jour)
111.67%
Changement (1 an)
0.00%
Pays
FR
Échange Pharnext S.A. (ALPHA)

Catégorie

Healthcare
Ratio P/B pour Pharnext S.A. (ALPHA)
Ratio P/B au August 2026 TTM : 0.00
Selon les derniers rapports financiers et le cours de l'action de Pharnext S.A., le ratio cours/valeur comptable actuel (TTM) est 0.00. À la fin de 2022, le ratio P/B était de -303.89M.
Historique du ratio P/B pour Pharnext S.A. de 2012 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.00 -100.00%
2023 -0.02 -100.00%
2022 -303.89M -100.00%
2021 -18.548T -96.18%
2020 -485.040T -66.25%
2019 -1.44Qa 95.99%
2018 -733.358T -44.70%
2017 -1.33Qa -129.61%
2016 4.48Qa -660.02%
2015 -799.743T -45.58%
2014 -1.47Qa -64.17%
2013 -4.10Qa 0.00%
2012 0.00 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR